Daniela Giunta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniela Giunta has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Maurizio Solinas
CNR Istituto di Chimica Biomolecolare UOS Sassari Traversa La Crucca 3 07100 Sassari Italy
8 shared publications Claudia Mugnaini
Department of Biotechnology Chemistry and Pharmacy, University of Siena, Siena, Italy
4 shared publications- Maria Paola Castelli
Department of Biomedical Sciences, University of Cagliari, Italy
4 shared publications Carla Lobina
Neuroscience Institute, National Research Council of Italy, Section of Cagliari, Cagliari, Italy
3 shared publications- Walter Leitner
Institut für Technische und Makromolekulare Chemie, RWTH Aachen University, Worringerweg 2, 52074 Aachen, Germany
3 shared publications Alberto Casti
Dipartimento di Scienze Biomediche, Divisione di Neuroscienze e Farmacologia Clinica, Cittadella Universitaria, S.S. 554, 09042 Monserrato, Cagliari, Italy
2 shared publications
Latest Publications
- 1 November 2016
- Published by Elsevier in European Journal of Pharmacology
- Vol. 791, 115-123
In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator
- 1 November 2016
- Published by Elsevier in European Journal of Pharmacology
- Vol. 791, 115-123
In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator
- 1 May 2015
- Published by Elsevier in Tetrahedron
- Vol. 71 (18) , 2692-2697
Novozym-435 as efficient catalyst for the synthesis of benzoic and (hetero)aromatic carboxylic acid esters
- 1 May 2015
- Published by Elsevier in Tetrahedron
- Vol. 71 (18) , 2692-2697
Novozym-435 as efficient catalyst for the synthesis of benzoic and (hetero)aromatic carboxylic acid esters
- 19 November 2013
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (4) , 1782-1793
Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof
We have previously reported the synthesis and the pharmacological characterization of a family of methyl 2-(acylamino)thiophene-3-carboxylates as GABAB positive allosteric modulators active both in vitro and in vivo. In the present work, we describe the synthesis of new compounds based on the bioisosteric replacement of the ester moiety with amido or heterocyclic groups as well as of thieno[2,3-d]pyrimidine derivatives as rigid analogues thereof. 4H-Thieno[2,3-d][1,3]oxazin-4-ones were used as synthetic intermediates for the preparation of some of these compounds. The structures of oxazinones 11b, 16, and 17 were assigned by X-ray crystallographic studies, which definitely ruled out the isomeric beta-lactam structure previously hypothesized for these compounds. None of the new molecules exhibited significant activity at the GABAB receptor, either as allosteric or orthosteric ligands.
- 19 November 2013
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (4) , 1782-1793
Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof
We have previously reported the synthesis and the pharmacological characterization of a family of methyl 2-(acylamino)thiophene-3-carboxylates as GABAB positive allosteric modulators active both in vitro and in vivo. In the present work, we describe the synthesis of new compounds based on the bioisosteric replacement of the ester moiety with amido or heterocyclic groups as well as of thieno[2,3-d]pyrimidine derivatives as rigid analogues thereof. 4H-Thieno[2,3-d][1,3]oxazin-4-ones were used as synthetic intermediates for the preparation of some of these compounds. The structures of oxazinones 11b, 16, and 17 were assigned by X-ray crystallographic studies, which definitely ruled out the isomeric beta-lactam structure previously hypothesized for these compounds. None of the new molecules exhibited significant activity at the GABAB receptor, either as allosteric or orthosteric ligands.
- 1 September 2013
- Published by Elsevier in Tetrahedron Letters
- Vol. 54 (37) , 5122-5125
Immobilised Candida antarctica B as efficient catalyst for the synthesis of local anaesthetic intermediates
- 1 September 2013
- Published by Elsevier in Tetrahedron Letters
- Vol. 54 (37) , 5122-5125
Immobilised Candida antarctica B as efficient catalyst for the synthesis of local anaesthetic intermediates
- 1 April 2013
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (9) , 3620-3635
Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABAB Receptor
Two recently reported hit compounds, COR627 and COR628, underpinned the development of a series of 2-(acylamino)thiophene derivatives. Some of these compounds displayed significant activity in vitro as positive allosteric modulators of the GABAB receptor by potentiating GTPγS stimulation induced by GABA at 2.5 and 25 μM while failing to exhibit intrinsic agonist activity. Compounds were also found to be effective in vivo, potentiating baclofen-induced sedation/hypnosis in DBA mice when administered either intraperitoneally or intragastrically. Although displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and 11 exhibited a higher efficacy in vivo: combination of these compounds with a per se nonsedative dose of baclofen resulted in shorter onset and longer duration of the loss of righting reflex in mice. Test compounds showed cytotoxic effects at concentrations comparable to or higher than those of GS39783 or BHF177.
- 1 April 2013
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 56 (9) , 3620-3635
Synthesis and Pharmacological Characterization of 2-(Acylamino)thiophene Derivatives as Metabolically Stable, Orally Effective, Positive Allosteric Modulators of the GABAB Receptor
Two recently reported hit compounds, COR627 and COR628, underpinned the development of a series of 2-(acylamino)thiophene derivatives. Some of these compounds displayed significant activity in vitro as positive allosteric modulators of the GABAB receptor by potentiating GTPγS stimulation induced by GABA at 2.5 and 25 μM while failing to exhibit intrinsic agonist activity. Compounds were also found to be effective in vivo, potentiating baclofen-induced sedation/hypnosis in DBA mice when administered either intraperitoneally or intragastrically. Although displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and 11 exhibited a higher efficacy in vivo: combination of these compounds with a per se nonsedative dose of baclofen resulted in shorter onset and longer duration of the loss of righting reflex in mice. Test compounds showed cytotoxic effects at concentrations comparable to or higher than those of GS39783 or BHF177.
- 1 March 2012
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 340 (3) , 529-538
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor
The potential efficacy of GABAB receptor agonists in the treatment of pain, drug addiction, epilepsy, cognitive dysfunctions, and anxiety disorders is supported by extensive preclinical and clinical evidence. However, the numerous side effects produced by the GABAB receptor agonist baclofen considerably limit the therapeutic use of this compound. The identification of positive allosteric modulators (PAMs) of the GABAB receptor may constitute a novel approach in the pharmacological manipulation of the GABAB receptor, leading to fewer side effects. The present study reports the identification of two novel compounds, methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), which act as GABAB PAMs in 1) rat cortical membranes and 2) in vivo assay. Both compounds potentiated GABA- and baclofen-stimulated guanosine 5′-O-(3-[35S]thio)-triphosphate binding to native GABAB receptors, while producing no effect when given alone. GABA concentration-response curves in the presence of fixed concentrations of COR627 and COR628 revealed an increase of potency of GABA rather than its maximal efficacy. In radioligand binding experiments [displacement of the GABAB receptor antagonist, 3-N-[1-((S)-3,4dichlorophenyl)-ethylaminol]-2-(S)hydroxypropyl cyclo-hexylmethyl phosphinic acid ([3H]CGP54626)], both COR627 and COR628 increased the affinity of high- and low-affinity binding sites for GABA, producing no effect when administered alone up to a concentration of 1 mM. In vivo experiments indicated that pretreatment with per se ineffective doses of COR627 and COR628 potentiated the sedative/hypnotic effect of baclofen. In conclusion, COR627 and COR628 may represent two additional tools for use in investigating the roles and functions of positive allosteric modulatory binding sites of the GABAB receptor.
- 1 March 2012
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 340 (3) , 529-538
Characterization of COR627 and COR628, Two Novel Positive Allosteric Modulators of the GABAB Receptor
The potential efficacy of GABAB receptor agonists in the treatment of pain, drug addiction, epilepsy, cognitive dysfunctions, and anxiety disorders is supported by extensive preclinical and clinical evidence. However, the numerous side effects produced by the GABAB receptor agonist baclofen considerably limit the therapeutic use of this compound. The identification of positive allosteric modulators (PAMs) of the GABAB receptor may constitute a novel approach in the pharmacological manipulation of the GABAB receptor, leading to fewer side effects. The present study reports the identification of two novel compounds, methyl 2-(1-adamantanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR627) and methyl 2-(cyclohexanecarboxamido)-4-ethyl-5-methylthiophene-3-carboxylate (COR628), which act as GABAB PAMs in 1) rat cortical membranes and 2) in vivo assay. Both compounds potentiated GABA- and baclofen-stimulated guanosine 5′-O-(3-[35S]thio)-triphosphate binding to native GABAB receptors, while producing no effect when given alone. GABA concentration-response curves in the presence of fixed concentrations of COR627 and COR628 revealed an increase of potency of GABA rather than its maximal efficacy. In radioligand binding experiments [displacement of the GABAB receptor antagonist, 3-N-[1-((S)-3,4dichlorophenyl)-ethylaminol]-2-(S)hydroxypropyl cyclo-hexylmethyl phosphinic acid ([3H]CGP54626)], both COR627 and COR628 increased the affinity of high- and low-affinity binding sites for GABA, producing no effect when administered alone up to a concentration of 1 mM. In vivo experiments indicated that pretreatment with per se ineffective doses of COR627 and COR628 potentiated the sedative/hypnotic effect of baclofen. In conclusion, COR627 and COR628 may represent two additional tools for use in investigating the roles and functions of positive allosteric modulatory binding sites of the GABAB receptor.
- 1 January 2012
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 39 (1) , 175-181
Bioconversion of ovine scotta into lactic acid with pure and mixed cultures of lactic acid bacteria
Scotta is the main by-product in the making of ricotta cheese. It is widely produced in southern Europe and particularly in Italy where it represents a serious environmental pollutant due to its high lactose content. With the aim of evaluating whether scotta bioconversion into lactic acid can be considered as an alternative to its disposal, besides providing it with an added value, here the growth, fermentative performances, and lactic acid productions of pure and mixed cultures of Lactobacillus casei, Lactobacillus helveticus, and Streptococcus thermophilus were evaluated on ovine scotta-based media, without and with the addition of nutritional supplements. The outcomes indicate that ovine scotta can be utilized for the biotechnological production of lactic acid with yields up to 92%, comparable to those obtained on cheese-whey. Indeed, the addition of nutritional supplements generally improves the fermentative performances of lactic acid bacteria leading to about 2 g l−1 h−1 of lactic acid. Moreover, the use of mixed cultures for scotta bioconversion reduces the need for nutritional supplements, with no detrimental effects on the productive parameters compared to pure cultures. Finally, by using L. casei and S. thermophilus in pure and mixed cultures, up to 99% optically pure l-lactic acid can be obtained.
- 1 January 2012
- Published by Oxford University Press (OUP) in Journal of Industrial Microbiology and Biotechnology
- Vol. 39 (1) , 175-181
Bioconversion of ovine scotta into lactic acid with pure and mixed cultures of lactic acid bacteria
Scotta is the main by-product in the making of ricotta cheese. It is widely produced in southern Europe and particularly in Italy where it represents a serious environmental pollutant due to its high lactose content. With the aim of evaluating whether scotta bioconversion into lactic acid can be considered as an alternative to its disposal, besides providing it with an added value, here the growth, fermentative performances, and lactic acid productions of pure and mixed cultures of Lactobacillus casei, Lactobacillus helveticus, and Streptococcus thermophilus were evaluated on ovine scotta-based media, without and with the addition of nutritional supplements. The outcomes indicate that ovine scotta can be utilized for the biotechnological production of lactic acid with yields up to 92%, comparable to those obtained on cheese-whey. Indeed, the addition of nutritional supplements generally improves the fermentative performances of lactic acid bacteria leading to about 2 g l−1 h−1 of lactic acid. Moreover, the use of mixed cultures for scotta bioconversion reduces the need for nutritional supplements, with no detrimental effects on the productive parameters compared to pure cultures. Finally, by using L. casei and S. thermophilus in pure and mixed cultures, up to 99% optically pure l-lactic acid can be obtained.
- 1 September 2009
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 13 (13) , 1300-1321
Beneficial Combination of Ionic Liquids and Carbon Dioxide in Transition Metal Catalysed Reactions
Compressed carbon dioxide (liquid or supercritical scCO2) and ionic liquids (ILs) are finding a constant interest as alternative green solvents for chemical reactions. Both systems have been employed alone as replacement of volatile organic compounds (VOCs) in a large number of stoichiometric and catalytic transformations sometimes leading to surprisingly improved results. The non volatility of ionic liquids and the benign nature of carbon dioxide are the major driving forces to their use as reaction media. Moreover, the tunability of their solvent properties by proper design (ILs) or by variation of pressure and temperature (scCO2) is an additional reason to their broader application. Both ionic liquids and carbon dioxide present some challenges but, ever since several researchers started to deeply investigate the phase behaviour of the combined system, it appeared how this may possibly be the way to overcome their limitations. The beneficial combination of the two non-traditional solvents has been confirmed by the numerous examples reported in the literature. With the present review the authors wish to discuss about the combination of ionic liquids and carbon dioxide applied to transition metal catalysed reactions with particular emphasis on the phase behaviour of the system.
- 1 September 2009
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 13 (13) , 1300-1321
Beneficial Combination of Ionic Liquids and Carbon Dioxide in Transition Metal Catalysed Reactions
Compressed carbon dioxide (liquid or supercritical scCO2) and ionic liquids (ILs) are finding a constant interest as alternative green solvents for chemical reactions. Both systems have been employed alone as replacement of volatile organic compounds (VOCs) in a large number of stoichiometric and catalytic transformations sometimes leading to surprisingly improved results. The non volatility of ionic liquids and the benign nature of carbon dioxide are the major driving forces to their use as reaction media. Moreover, the tunability of their solvent properties by proper design (ILs) or by variation of pressure and temperature (scCO2) is an additional reason to their broader application. Both ionic liquids and carbon dioxide present some challenges but, ever since several researchers started to deeply investigate the phase behaviour of the combined system, it appeared how this may possibly be the way to overcome their limitations. The beneficial combination of the two non-traditional solvents has been confirmed by the numerous examples reported in the literature. With the present review the authors wish to discuss about the combination of ionic liquids and carbon dioxide applied to transition metal catalysed reactions with particular emphasis on the phase behaviour of the system.
- 1 December 2008
- Published by Elsevier in Tetrahedron
- Vol. 64 (51) , 11768-11775
Short and highly stereoselective total synthesis of d-ribo-configured ureido sugars
- 1 December 2008
- Published by Elsevier in Tetrahedron
- Vol. 64 (51) , 11768-11775
Short and highly stereoselective total synthesis of d-ribo-configured ureido sugars
- 18 January 2007
- Published by Wiley in Chemistry – A European Journal
- Vol. 13 (5) , 1539-1546
Synthesis and Characterisation of Nonclassical Ruthenium Hydride Complexes Containing Chelating Bidentate and Tridentate Phosphine Ligands
The synthesis and characterisation of nonclassical ruthenium hydride complexes containing bidentate PP and tridentate PCP and PNP pincer‐type ligands are described. The mononuclear and dinuclear ruthenium complexes presented have been synthesised in moderate to high yields by the direct hydrogenation route (one‐pot synthesis) or in a two‐step procedure. In both cases [Ru(cod)(metallyl)2] served as a readily available precursor. The influences of the coordination geometry and the ligand framework on the structure, binding, and chemical properties of the MH2 fragments were studied by X‐ray crystal structure analysis, spectroscopic methods, and reactivity towards N2, D2, and deuterated solvents.
- 18 January 2007
- Published by Wiley in Chemistry – A European Journal
- Vol. 13 (5) , 1539-1546
Synthesis and Characterisation of Nonclassical Ruthenium Hydride Complexes Containing Chelating Bidentate and Tridentate Phosphine Ligands
The synthesis and characterisation of nonclassical ruthenium hydride complexes containing bidentate PP and tridentate PCP and PNP pincer‐type ligands are described. The mononuclear and dinuclear ruthenium complexes presented have been synthesised in moderate to high yields by the direct hydrogenation route (one‐pot synthesis) or in a two‐step procedure. In both cases [Ru(cod)(metallyl)2] served as a readily available precursor. The influences of the coordination geometry and the ligand framework on the structure, binding, and chemical properties of the MH2 fragments were studied by X‐ray crystal structure analysis, spectroscopic methods, and reactivity towards N2, D2, and deuterated solvents.